Crombé Amandine, Bertolo Frédéric, Fadli David, Kind Michèle, Le Loarer François, Perret Raul, Chaire Vanessa, Spinnato Paolo, Lucchesi Carlo, Italiano Antoine
Department of Oncologic Imaging, Institut Bergonié, Comprehensive Cancer Center, F-33076, Bordeaux, France.
Models in Oncology (MONC) Team, INRIA Bordeaux Sud-Ouest, CNRS UMR 5251 & Bordeaux University, F-33400, Talence, France.
Eur Radiol. 2023 Feb;33(2):1205-1218. doi: 10.1007/s00330-022-09104-8. Epub 2022 Aug 27.
Radiomics of soft tissue sarcomas (STS) is assumed to correlate with histologic and molecular tumor features, but radiogenomics analyses are lacking. Our aim was to identify if distinct patterns of natural evolution of STS obtained from consecutive pre-treatment MRIs are associated with differential gene expression (DGE) profiling in a pathway analysis.
All patients with newly diagnosed STS treated in a curative intent in our sarcoma reference center between 2008 and 2019 and with two available pre-treatment contrast-enhanced MRIs were included in this retrospective study. Radiomics features (RFs) were extracted from fat-sat contrast-enhanced T1-weighted imaging. Log ratio and relative change in RFs were calculated and used to determine grouping of samples based on a consensus hierarchical clustering. DGE and oncogenesis pathway analysis were performed in the delta-radiomics groups identified in order to detect associations between delta-radiomics patterns and transcriptomics features of STS. Secondarily, the prognostic value of the delta-radiomics groups was investigated.
Sixty-three patients were included (median age: 63 years, interquartile range: 52.5-70). The consensus clustering identified 3 reliable delta-radiomics patient groups (A, B, and C). On imaging, group B patients were characterized by increase in tumor heterogeneity, necrotic signal, infiltrative margins, peritumoral edema, and peritumoral enhancement before the treatment start (p value range: 0.0019-0.0244), and, molecularly, by downregulation of natural killer cell-mediated cytotoxicity genes and upregulation of Hedgehog and Hippo signaling pathways. Group A patients were characterized by morphological stability of pre-treatment MRI traits and no local relapse (log-rank p = 0.0277).
This study highlights radiomics and transcriptomics convergence in STS. Proliferation and immune response inhibition were hyper-activated in the STS that were the most evolving on consecutive imaging.
• Three consensual and stable delta-radiomics clusters were identified and captured the natural patterns of morphological evolution of STS on pre-treatment MRIs. • These 3 patterns were explainable and correlated with different well-known semantic radiological features with an ascending gradient of pejorative characteristics from the A group to C group to B group. • Gene expression profiling stressed distinct patterns of up/downregulated oncogenetic pathways in STS from B group in keeping with its most aggressive radiological evolution.
软组织肉瘤(STS)的放射组学被认为与组织学和分子肿瘤特征相关,但缺乏放射基因组学分析。我们的目的是在通路分析中确定从连续的治疗前MRI获得的STS自然演变的不同模式是否与差异基因表达(DGE)谱相关。
本回顾性研究纳入了2008年至2019年在我们肉瘤参考中心接受根治性治疗且有两次可用的治疗前对比增强MRI的所有新诊断STS患者。从脂肪饱和对比增强T1加权成像中提取放射组学特征(RFs)。计算RFs的对数比和相对变化,并用于基于一致性层次聚类确定样本分组。对确定的δ放射组学组进行DGE和肿瘤发生通路分析,以检测δ放射组学模式与STS转录组学特征之间的关联。其次,研究了δ放射组学组的预后价值。
纳入63例患者(中位年龄:63岁,四分位间距:52.5 - 70)。一致性聚类确定了3个可靠的δ放射组学患者组(A、B和C)。在影像学上,B组患者的特征是在治疗开始前肿瘤异质性增加、坏死信号、浸润性边缘、瘤周水肿和瘤周强化(p值范围:0.0019 - 0.0244),在分子水平上,自然杀伤细胞介导的细胞毒性基因下调以及刺猬信号通路和河马信号通路上调。A组患者的特征是治疗前MRI特征的形态稳定性且无局部复发(对数秩p = 0.0277)。
本研究突出了STS中放射组学和转录组学的趋同性。在连续成像中变化最大的STS中,增殖和免疫反应抑制被过度激活。
• 确定了3个一致且稳定的δ放射组学簇,并捕捉了治疗前MRI上STS形态演变的自然模式。• 这3种模式是可解释的,并且与不同的众所周知的语义放射学特征相关,从A组到C组再到B组,贬义特征呈上升梯度。• 基因表达谱强调了B组STS中致癌通路上调/下调的不同模式,与其最具侵袭性的放射学演变一致。